Legal status | |
---|---|
Legal status |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H18FNO |
Molar mass | 235.302 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Fluorexetamine (3'-Fluoro-2-oxo-PCE, 3-FXE) is a recreational designer drug from the arylcyclohexylamine family, with dissociative effects. It has reportedly been sold over the internet since around 2017, though has remained relatively uncommon.
In April 2023 it was revealed by DrugsData.org that all their previously analyzed samples of fluorexetamine actually contained 2'-Fluoro-2-oxo-PCE (2-FXE, also known as CanKet) rather than 3'-Fluoro-2-oxo PCE (3-FXE). This was confirmed by a newly available reference standard for 2-FXE. Similar misidentification may have occurred in other laboratories.
See also
- 2-Fluorodeschloroketamine
- 2F-NENDCK
- 3-Fluorodeschloroketamine
- 3-Fluoro-PCP
- Deoxymethoxetamine
- Hydroxetamine
- Methoxetamine
- MXiPr
References
- Wallach J, Brandt SD (2018). "1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances". Handbook of Experimental Pharmacology. 252: 305–352. doi:10.1007/164_2018_148. ISBN 978-3-030-10560-0. PMID 30196446.
- Erowid, DrugsData org /. "DrugsData.org (was EcstasyData): Test Details : Result #15191 - White Crystals, 15191". www.drugsdata.org. Retrieved 2023-12-02.
This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |